Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women

Lorna Thorpe, Margaret Frederick, Jane Pitt, Irene Cheng, D. Heather Watts, Shelley Buschur, Karen Green, Carmen Zorrilla, Sheldon H. Landesman, Ronald C. Hershow

Research output: Contribution to journalArticle

Abstract

In vitro and animal studies suggest that cocaine and heroin increase HIV replication and suppress immune function, whereas epidemiologic studies are inconclusive regarding their effect on HIV infection progression. The authors prospectively examined the association between illicit-drug use and 4 outcome measures (CD4 cell percentage, HIV RNA level, survival to class C diagnosis of HIV infection, and death) in a national cohort of HIV-infected women. Women enrolled between 1989 and 1995 were followed for 5 years and repeatedly interviewed about illicit ("hard")-drug use. Up to 3 periodic urine screens validated self-reported use. Outcomes were compared between hard-drug users (women using cocaine, heroin, methadone, or injecting drugs) and nonusers, adjusting for age, antiretroviral therapy, number of pregnancies, smoking, and baseline CD4 cell percentage. Of 1148 women, 40% reported base-line hard-drug use during pregnancy. In multivariate analyses, hard-drug use was not associated with change in CD4 cell percentage (P = 0.84), HIV RNA level (P = 0.48), or all-cause mortality (relative hazard = 1.10; 95% confidence interval, 0.61-1.98). Hard-drug users did, however, exhibit a higher risk of developing class C diagnoses (relative hazard = 1.65; 95% confidence interval, 1.00-2.72), especially herpes, pulmonary tuberculosis, and recurrent pneumonia. Hard-drug-using women may have a higher risk for nonfatal opportunistic infections.

Original languageEnglish (US)
Pages (from-to)1423-1430
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume37
Issue number3
DOIs
StatePublished - Nov 1 2004

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
RNA
Pharmaceutical Preparations
Heroin
Street Drugs
Drug Users
Cocaine
HIV Infections
Confidence Intervals
Pregnancy
Methadone
Opportunistic Infections
Pulmonary Tuberculosis
Epidemiologic Studies
Pneumonia
Multivariate Analysis
Smoking
Outcome Assessment (Health Care)
Urine

Keywords

  • AIDS
  • CD4 lymphocyte count
  • Disease progression
  • Drug use
  • HIV
  • HIV RNA level

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. / Thorpe, Lorna; Frederick, Margaret; Pitt, Jane; Cheng, Irene; Watts, D. Heather; Buschur, Shelley; Green, Karen; Zorrilla, Carmen; Landesman, Sheldon H.; Hershow, Ronald C.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 37, No. 3, 01.11.2004, p. 1423-1430.

Research output: Contribution to journalArticle

Thorpe, Lorna ; Frederick, Margaret ; Pitt, Jane ; Cheng, Irene ; Watts, D. Heather ; Buschur, Shelley ; Green, Karen ; Zorrilla, Carmen ; Landesman, Sheldon H. ; Hershow, Ronald C. / Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. In: Journal of Acquired Immune Deficiency Syndromes. 2004 ; Vol. 37, No. 3. pp. 1423-1430.
@article{703988c04b3645759ec76d9895432a7c,
title = "Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women",
abstract = "In vitro and animal studies suggest that cocaine and heroin increase HIV replication and suppress immune function, whereas epidemiologic studies are inconclusive regarding their effect on HIV infection progression. The authors prospectively examined the association between illicit-drug use and 4 outcome measures (CD4 cell percentage, HIV RNA level, survival to class C diagnosis of HIV infection, and death) in a national cohort of HIV-infected women. Women enrolled between 1989 and 1995 were followed for 5 years and repeatedly interviewed about illicit ({"}hard{"})-drug use. Up to 3 periodic urine screens validated self-reported use. Outcomes were compared between hard-drug users (women using cocaine, heroin, methadone, or injecting drugs) and nonusers, adjusting for age, antiretroviral therapy, number of pregnancies, smoking, and baseline CD4 cell percentage. Of 1148 women, 40{\%} reported base-line hard-drug use during pregnancy. In multivariate analyses, hard-drug use was not associated with change in CD4 cell percentage (P = 0.84), HIV RNA level (P = 0.48), or all-cause mortality (relative hazard = 1.10; 95{\%} confidence interval, 0.61-1.98). Hard-drug users did, however, exhibit a higher risk of developing class C diagnoses (relative hazard = 1.65; 95{\%} confidence interval, 1.00-2.72), especially herpes, pulmonary tuberculosis, and recurrent pneumonia. Hard-drug-using women may have a higher risk for nonfatal opportunistic infections.",
keywords = "AIDS, CD4 lymphocyte count, Disease progression, Drug use, HIV, HIV RNA level",
author = "Lorna Thorpe and Margaret Frederick and Jane Pitt and Irene Cheng and Watts, {D. Heather} and Shelley Buschur and Karen Green and Carmen Zorrilla and Landesman, {Sheldon H.} and Hershow, {Ronald C.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1097/01.qai.0000127354.78706.5d",
language = "English (US)",
volume = "37",
pages = "1423--1430",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women

AU - Thorpe, Lorna

AU - Frederick, Margaret

AU - Pitt, Jane

AU - Cheng, Irene

AU - Watts, D. Heather

AU - Buschur, Shelley

AU - Green, Karen

AU - Zorrilla, Carmen

AU - Landesman, Sheldon H.

AU - Hershow, Ronald C.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - In vitro and animal studies suggest that cocaine and heroin increase HIV replication and suppress immune function, whereas epidemiologic studies are inconclusive regarding their effect on HIV infection progression. The authors prospectively examined the association between illicit-drug use and 4 outcome measures (CD4 cell percentage, HIV RNA level, survival to class C diagnosis of HIV infection, and death) in a national cohort of HIV-infected women. Women enrolled between 1989 and 1995 were followed for 5 years and repeatedly interviewed about illicit ("hard")-drug use. Up to 3 periodic urine screens validated self-reported use. Outcomes were compared between hard-drug users (women using cocaine, heroin, methadone, or injecting drugs) and nonusers, adjusting for age, antiretroviral therapy, number of pregnancies, smoking, and baseline CD4 cell percentage. Of 1148 women, 40% reported base-line hard-drug use during pregnancy. In multivariate analyses, hard-drug use was not associated with change in CD4 cell percentage (P = 0.84), HIV RNA level (P = 0.48), or all-cause mortality (relative hazard = 1.10; 95% confidence interval, 0.61-1.98). Hard-drug users did, however, exhibit a higher risk of developing class C diagnoses (relative hazard = 1.65; 95% confidence interval, 1.00-2.72), especially herpes, pulmonary tuberculosis, and recurrent pneumonia. Hard-drug-using women may have a higher risk for nonfatal opportunistic infections.

AB - In vitro and animal studies suggest that cocaine and heroin increase HIV replication and suppress immune function, whereas epidemiologic studies are inconclusive regarding their effect on HIV infection progression. The authors prospectively examined the association between illicit-drug use and 4 outcome measures (CD4 cell percentage, HIV RNA level, survival to class C diagnosis of HIV infection, and death) in a national cohort of HIV-infected women. Women enrolled between 1989 and 1995 were followed for 5 years and repeatedly interviewed about illicit ("hard")-drug use. Up to 3 periodic urine screens validated self-reported use. Outcomes were compared between hard-drug users (women using cocaine, heroin, methadone, or injecting drugs) and nonusers, adjusting for age, antiretroviral therapy, number of pregnancies, smoking, and baseline CD4 cell percentage. Of 1148 women, 40% reported base-line hard-drug use during pregnancy. In multivariate analyses, hard-drug use was not associated with change in CD4 cell percentage (P = 0.84), HIV RNA level (P = 0.48), or all-cause mortality (relative hazard = 1.10; 95% confidence interval, 0.61-1.98). Hard-drug users did, however, exhibit a higher risk of developing class C diagnoses (relative hazard = 1.65; 95% confidence interval, 1.00-2.72), especially herpes, pulmonary tuberculosis, and recurrent pneumonia. Hard-drug-using women may have a higher risk for nonfatal opportunistic infections.

KW - AIDS

KW - CD4 lymphocyte count

KW - Disease progression

KW - Drug use

KW - HIV

KW - HIV RNA level

UR - http://www.scopus.com/inward/record.url?scp=7244240644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244240644&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000127354.78706.5d

DO - 10.1097/01.qai.0000127354.78706.5d

M3 - Article

C2 - 15483472

AN - SCOPUS:7244240644

VL - 37

SP - 1423

EP - 1430

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -